China SXT Pharmaceuticals Raises $9 Million in Direct Offering, Shares Dip 1–2%
China SXT Pharmaceuticals raises $9 M in a July 2026 registered direct offering, boosting capital for Chinese medicine R&D while briefly impacting its Nasdaq stock price.
2 minutes to read